| Market Cap | ₹16,788Cr |
| ROE | 15.93% |
| P/E Ratio(TTM) | 57.50 |
| EPS(TTM) | 35.66 |
| P/B Ratio | 11.85 |
| Dividend Yield | 0.07% |
| Industry P/E | 40.03 |
| Book Value | 173.03 |
| Debt to Equity | 0.01 |
| Face Value | 5 |
| Managing Director | Nareshkumar Patel |
| Founded | 2007 |
| NSE Symbol | ACUTAAS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 65.94 | ||
| Neuland Laboratories | NA (0.00%) | 96.58 | ||
| Jubilant Pharmova | NA (0.00%) | 34.72 | ||
| Gujarat Themis Biosyn | NA (0.00%) | 77.24 |